Calyxia designs and industrially produces a new class of microcapsules that are transforming the way the world makes formulated products.
Calyxia has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
Calyxia's investors include Astanor Ventures, EASME, Lombard Odier Investment Managers, Bpifrance Large Venture.
Calyxia is headquartered in Bonneuil-sur-marne, France.
Calyxia designs and industrially produces a new class of microcapsules that are transforming the way the world makes formulated products.
Calyxia is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Calyxia — Funding & Investors." VCBacked, September 5, 2024, https://www.vcbacked.co/company/calyxia. Accessed October 29, 2026.
VCBacked. (2024). Calyxia — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/calyxia
{{cite web |title=Calyxia — Funding & Investors |url=https://www.vcbacked.co/company/calyxia |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated